Alicia Castañeda Heredia
Investigador
Research group
Professional network profiles
Last Publications
- Ferrari A, Provenzano S, Prampolini C, van der Graaf W, Husson O, Morgan JD, Quarello P, Cristina Larrosa Espinosa, Castañeda-Heredia A, Peccatori F, Stark D, Laurence V, Gaspar N, Poirel HA, Van Aelst F, Franceschi E, Saloustros E, Dirksen U, Kienesberger A, Schneider C, Murphy I, Kosir U, Rizvi K, Fiorente M, Casali P and Trama A Advancing cancer care for adolescents and young adults: the role of the European Network of Expertise. ESMO Open . 11(10): 108542-108542.
- Vilaplana A, Carolina Torres A, Escudero López A, Izquierdo E, Manresa-Vera S, Escrivá-Fernández J, Alba-Pavón P, Alaña L, Gutierrez-Camino A, Rodríguez-Antolín C, Venegas Mascaró C, Paco-Mercader S, Salvador-Marcos N, Chamorro-Vera A, Imízcoz T, Panizo Morgado E, Vergara-Muñoz B, Juan-Ribelles A, Benavent N, Castañeda-Heredia A, Rovira-Zurriaga C, Valero-Arrese L, Díaz-Merchán R, Manzano-Benito I, Cervera ST, García-Calvo L, Jiménez I, Domínguez-Pinilla N, Nova-Lozano C, Cuadrado-Torroglosa I, Sánchez-Ruiz J, Mondejar T, Pérez-Martínez A, Fernández-Teijeiro A, Solano-Páez P, Roma J, Font de Mora J, Meléndez B, Rubio-San-Simón A, Saiz-Ladera C, Astigarraga I, Cañete A, Alonso J, Lavarino C, Patiño-García A, Moreno L and Soriano A Establishing a Multicenter Personalized Medicine Program in Childhood, Adolescent, and Young Adult Cancer in Spain: The SEHOP-PENCIL Project. JCO Precision Oncology . 10(9): .
- Kuhlen M, Roganivic J, Naviglio S, Baecklund F, Bello R, Ben-Ami T, Bergamaschi L, Bilic E, Bien E, Brito MJ, Castañeda-Heredia A, Cesen Mazic M, Dos Reis Farinha NJ, Jovanovska A, de Krijger R, Debora de Pasquale M, Elisei R, Grau Bolado G, Guillén G, Haissaguerre M, Hartl D, Huerta-Aragonés J, Krawczyk MA, Lamartina L, Leite F, Leite V, López Almaraz R, Manevska N, Mansuy L, Miele E, Naderi EH, Nordmann Winther T, Petit IO, Özön ZA, Podda MG, Pourtsidis A, Reguerre Y, Sandström M, Schneider DT, Ekinci S, Suput Omladic J, Sztangierska B, Verite C, Waespe N, Wong KH, Yalcin B, Abele M, Bisogno G, Orbach D, Brecht IB, Virgone C and Redlich A Who leads, who treats, what dose? European paediatric differentiated thyroid carcinoma practice-an European Cooperative Study Group for Paediatric Rare Tumours survey EUROPEAN JOURNAL OF ENDOCRINOLOGY . 194(6): 756-768.
Projects
- Project name:
- Disrupción de enhancers: la nueva generación de terapia epigenética en el sarcoma de Ewing
- Leader
- Jaume Mora Graupera, Sara Sánchez Molina
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- PI24/00804
- Starting - finishing date:
- 2025 - 2027
- Project name:
- ICF (Exploratory study on the provision of care for Adolescent and Young Adult (AYA) cancer patients in the Union)
- Leader
- Andrés Morales La Madrid
- Funding entities:
- European Commission
- Code
- 330301961
- Starting - finishing date:
- 2025 - 2026
- Project name:
- SEHOP-PENCIL study - Personalised mEdiciNe for Cancer in chILdren in Spain
- Leader
- Cinzia Emilia Lavarino
- Funding entities:
- Lavarino, Cinzia Emilia, Instituto de Salud Carlos III (ISCIII), Fundació Privada per a la Recerca i la Docència Sant Joan de Déu - FSJD
- Code
- PMP21/00075
- Starting - finishing date:
- 2022 - 2026
News
-
Survival rate of high-risk neuroblastoma patients treated with next-generation immunotherapy at SJD Barcelona Children's Hospital
Researchers of SJD Barcelona Children's Hospital and of Institut de Recerca Sant Joan de Déu (IRSJD) have published the results of treatment with the humanised anti-GD2 antibody Naxitamab (DanyelzaR) combined with granulocyte-macrophage colony-stimulating factor (GM-CSF; LeukineR) in high-risk neuroblastoma patients.
